This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


Advertisement


Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us   Dec. 6, 2013


Advertisement

Advertisement
 

Advertisement


Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation
Transplantation (login required)
Nonalcoholic steatohepatitis (NASH) is increasingly recognized as the most common chronic liver disease worldwide. The aim of this study is to investigate the transplantation trends of liver transplant recipients with NASH. Using the United Network for Organ Sharing database, study authors found a steady increase in LT rate especially in those more than 65 years old.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement


SOCIETY NEWS


AST research grant funding: One week left to apply!
AST
Are you considering applying for an AST/TRI research grant? If so, submit your application today! Completed applications must be submitted by Monday, Dec. 16. For criteria and eligibility, click here.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Journal Club Dec. 13: 'Kidney Allograft Survival After Acute Rejection, the Value of Follow-Up Biopsies'
AST
Join authors, Drs. Fernando Cosio and Mireille El Ters, of the Mayo Clinic, Rochester for a review and discussion of their September 2013 AJT article. Pre-register today!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
 


Nominate your colleague for an AST Achievement Award
AST
Recognize the accomplishments of a fellow AST member with a nomination for an AST Achievement Award. Ten different awards recognize excellence in the field of transplantation. Nominations are due by Monday, Dec. 16. Submit your nomination today!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRANSPLANT NEWS


Incidence and predictors of postoperative atrial fibrillation in kidney transplant recipients
NCBI
Postoperative atrial fibrillation (POAF) is a complication of cardiothoracic and noncardiothoracic surgery. Kidney transplant recipients bear several known risk factors and may have a higher incidence of POAF. Authors retrospectively studied kidney and kidney/liver transplant recipients to estimate their POAF incidence and identify relevant risk factors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Gastric bypass after liver transplantation
Liver Transplantation (login required)
Few data are available for assessing the outcomes of bariatric surgery for patients who have undergone orthotopic liver transplantation (OLT). The University of Minnesota bariatric surgery database and transplant registry were retrospectively reviewed to identify patients who had undergone OLT and then open Roux-en-Y gastric bypass surgery between 2001 and 2009. Comorbidity-appropriate laboratory values, body mass indices, histopathology reports and immunosuppressive regimens were collected.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon
The Journal of Heart and Lung Transplantation (login required)
Continuous-flow left ventricular assist devices (CF-LVADs) are increasingly used to support patients with advanced heart failure. Device thrombosis is a serious complication of CF-LVADs, but its precise prevalence and etiology remains uncertain. Root-cause analysis was performed in all cases with device thrombosis confirmed upon explant among patients implanted with a HeartMate II (HM II) from Jan. 1, 2009 to Nov. 15, 2012. Cannula position and bend relief integrity were assessed and charts were reviewed with particular attention to anti-coagulation and infection profiles.

Related article:
Unexpected abrupt increase in left ventricular assist device thrombosis (The New England Journal of Medicine)

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Featured Advertisers


Diagnose faster, when it matters most.
For nearly 30 years, physicians have trusted Viracor-IBT Laboratories to provide accelerated results, specialized expertise and exceptional service in transplant testing. Learn more at www.viracoribt.com.
Advertise here!

To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact Tom Crist at 972-402-7724.
MORE


Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation
Transplant Infectious Disease
Cytomegalovirus (CMV) infection is one of the most common and important opportunistic infections following kidney transplantation. It causes significant morbidity and mortality. Valganciclovir (VGCV) is the drug of choice for prophylaxis to prevent CMV infection. Authors of this study conducted a post-hoc analysis of a randomized controlled trial in 187 kidney transplant recipients to evaluate the impact of VGCV dosing and renal function on the development of CMV infection.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
 
Astellas is entering its 20th year focusing on transplant immunology. Today we remain steadfast in our commitment to advancing the field. Tomorrow we will seek new possibilities to help improve the transplant experience. Together. Please visit astellas.us
 


Heart and combined heart-kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure
American Journal of Transplantation (login required)
In patients with end-stage heart failure (ESHF) who are candidates for isolated heart transplant (HRT), dialysis dependence (DD) is considered an indication for combined heart–kidney transplantation (HKT). HKT remains controversial in ESHF transplant candidates with nondialysis-dependent renal insufficiency (NDDRI). Using United Network for Organ Sharing data, authors examined the cumulative incidences of transplant and mortality in patients with DD and NDDRI waitlisted for HKT or HRT.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    AST president attends White House Oval Office signing of HOPE Act (AST)
Randomized controlled pilot study of b cell-targeted induction therapy in HLA sensitized kidney transplant recipients (American Journal of Transplantation)
Intrarenal resistive index after renal transplantation (The New England Journal of Medicine)
Effects of cardiovascular comorbidity adjustment on SRTR risk-adjusted cox proportional hazard models of graft survival (Transplantation)
Journal Club Dec. 13: "Kidney Allograft Survival After Acute Rejection, the Value of Follow-Up Biopsies" (AST)

Don't be left behind. Click here to see what else you missed.


Transplant may benefit patients with tumors of gastroentero-pancreatic origin
Healio
The competitive survival rates achieved using nontransplantation options for patients with metastatic neuroendocrine tumors of gastroentero-pancreatic origin along with the lack of accepted selection criteria has made the use of liver transplant in these cases controversial. A long-term study, however, has demonstrated significant transplant-associated survival benefit in these patients that may support the use of a MELD exception.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Outcomes of simultaneous liver and kidney transplantation in relation to a high level of preformed donor-specific antibodies
Transplantation (login required)
The protective effect of the liver allograft when simultaneously transplanted with a kidney in the setting of allosensitization is unclear. In a recent study, researchers analyzed the significance of sensitization, defined based on positive cytotoxicity crossmatches, positive flow cytometry crossmatches and/or the presence of high levels of donor-specific antibodies, on the outcomes of simultaneous liver and kidney transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Courtney Hodges, Content Editor, 972.402.2604   
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Nov. 27, 2013
Nov. 22, 2013
Nov. 15, 2013
Nov.8, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063